Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,007 | -15,292 | -11,798 | -9,499 | -1,407 |
| Depreciation Amortization | 91 | 564 | 476 | 391 | 217 |
| Accounts receivable | N/A | 12 | 12 | 12 | 10 |
| Accounts payable and accrued liabilities | 512 | -9,917 | -10,591 | -9,799 | -9,304 |
| Other Working Capital | -177 | -9,491 | -9,580 | -9,468 | -10,151 |
| Other Operating Activity | -173 | 4,734 | 5,885 | 7,510 | 4,572 |
| Operating Cash Flow | $-4,754 | $-29,390 | $-25,596 | $-20,853 | $-16,063 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87 | -252 | -186 | -143 | -58 |
| Investing Cash Flow | $-87 | $-252 | $-186 | $-143 | $-58 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2 | -2 | -2 | -2 |
| Other Financing Activity | 7,886 | 17,891 | 17,799 | -109 | -50 |
| Financing Cash Flow | $7,886 | $17,889 | $17,797 | $-111 | $-52 |
| Beginning Cash Position | 17,515 | 29,268 | 29,268 | 29,268 | 29,268 |
| End Cash Position | 20,560 | 17,515 | 21,283 | 8,161 | 13,095 |
| Net Cash Flow | $3,045 | $-11,753 | $-7,985 | $-21,107 | $-16,173 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,754 | -29,390 | -25,596 | -20,853 | -16,063 |
| Capital Expenditure | -87 | -253 | -187 | -143 | -58 |
| Free Cash Flow | -4,841 | -29,643 | -25,783 | -20,996 | -16,121 |